The U.S. Food and Drug Administration on Friday agreed to reconsider a decision it made last month to bar drug compounders ...

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

The Food and Drug Administration (FDA) said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and ...

Eli Lilly's weight-loss drug is no longer on the Food and Drug Administration's drug shortage list. Compounding pharmacies say this will limit patient access.

The FDA decision will enable Antag Therapeutics to initiate the clinical development of its lead candidate drug, a ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

The FDA has approved an ingestible event marker from the privately-held digital health company etectRx, as its rival “digital pill” company ... on the skin. The news of a potential competitor ...

When it comes to coverage for the pricey GLP-1 weight-loss drugs Wegovy ... of good and bad bacteria, a new study in mice indicates. Health News // 3 days ago FDA approves first once-weekly ...

The FDA has approved new versions of Pfizer/BioNTech's Comirnaty ... regulatory approval for PI3K inhibitor Itovebi, clearing the drug as part of a triple therapy for certain types of locally ...

Inquiries include a broad range of topics related to the regulations of new, generic, and nonprescription drugs, as well as clinical aspects related to individual drug products and drug classes.

From Elon Musk to Chelsea Handler, find out which celebrities have admitted to taking Ozempic for weight loss ... the exact drug. “The fact that there’s a medically approved prescription ...

For the first time in more than two decades, a completely new form of antipsychotic medication ... insurance providers will cover such a drug, given the abundance of cheaper alternatives. The FDA has ...